Romero-Lopez, Mar http://orcid.org/0000-0002-5890-7786
Tyson, Jon E.
Naik, Mamta
Pedroza, Claudia
Holzapfel, Lindsay F.
Avritscher, Elenir
Mosquera, Ricardo
Khan, Amir
Rysavy, Matthew
Funding for this research was provided by:
National Center for Advancing Translational Sciences (KL2 Career Development Award (5KL2TR003168))
Gerber Foundation (10287)
Article History
Received: 18 March 2024
Accepted: 19 June 2024
First Online: 28 June 2024
Declarations
:
: Parents or legal guardians of patients are approached after screening. Informed consent is obtained by a research team member, preferably in person in English or Spanish, or via phone interpreter from the participant’s parent or legal guardian. The IRB at McGovern Medical School approved this protocol (HSC-MS-22-0563) and consent form on July 12, 2022. Protocol amendments will be updated via ClinicalTrials.gov. All methods are being carried out in accordance with relevant guidelines and regulations.
: Not applicable—no identifying images or other personal or clinical details of participants are presented here or will be presented in reports of the trial results. The participant information materials and informed consent form are available from the corresponding author on request.
: The authors declare that they have no competing interests.